Selling to Private Equity vs. a Strategic Buyer: Who Pays More — and What You Give Up

Owners at the upper end of a sale get both calls. A competitor, a supplier, or a larger company in the same industry wants the business. A private equity firm, or a company that firm already owns, wants it too. The strategic often opens with a higher number. The equity firm often opens with a cleaner story about cash, a second sale, and a role if you stay. Those are different offers. The higher headline is not automatically the better exit.

The short answer: a strategic buyer can pay more when your profit drops to their bottom line through cost they can actually cut, customers they already serve, or a plant or product they do not have to build. Private equity pays for the company as a standalone platform, or as an add-on to a company they own, and they pay you partly in a minority stake you cannot spend. You give the strategic your brand, your team’s overlap, and usually a clean departure. You give the equity firm a board, a reporting calendar, a hold of several years, and a share of the next sale.

Our exit-planning work treats a strategic sale as one path. This guide is the comparison owners ask for when both kinds of buyers are in the process. If you are still deciding whether the company is large enough for either call, start with what changes when a sale crosses $20 million.

This article is not tax, legal, or investment advice. Rollover, synergies, and a second sale are fact-specific. Confirm the structure with counsel and a CPA before you sign a letter of intent.

How a Strategic Buyer Prices the Company

A strategic buyer already operates in or next to your business. They are not buying a stock they hope to sell in five years as their only plan. They are buying something they will fold in: a customer list, a territory, a product line, a plant, a license, a team.

They start from your earnings, then they add synergies — profit they believe they will have after they own you, which you do not have today.

Cost synergies are the ones that survive diligence. Duplicate overhead. A purchasing contract they already have at a better price. A plant they can fill with your volume. Insurance, software, a second accounting department. A buyer who can point to a line item on their own P&L will pay for it. A buyer who says “we will figure out the savings” will not, once their board sees the model.

Revenue synergies are the ones that get discounted. Cross-selling your product to their customers, or theirs to yours, sounds large in a management presentation. Most acquirers haircut it hard, or leave it out of the price, because it requires your customers to change behavior. If you are going to be paid for revenue synergies, get it in an earn-out with a definition you can audit, not in a speech. Our earn-out guide is the place those dollars go when the buyer will not put them in the wire.

A strategic can outbid a financial buyer when the fit is specific: they need your geography, your certification, your press, your code. They can also bid less than a sponsor when the only “synergy” is firing people you intend to protect, or when they are the one customer who already has the leverage. A competitor who knows your weaknesses will use diligence to take back the premium they teased.

What you often give up in a strategic sale:

• The name on the door, on a timetable they set
• Roles that overlap with people they already employ
• A second chapter in the same industry, through a non-compete that is the point of their purchase
• Speed, if the decision sits with a corporate board, a works council, or a parent company overseas
• The option to keep a stake, unless they offer one — many strategics want 100 percent

What you often keep is cash and a finish line. A strategic who wants the whole company, can fund it, and does not need you for three years is a real exit. That is the “clean departure” owners mean when they say they want out. It is clean only if the price is cash, the working capital and debt are defined, and the indemnity is capped.

How Private Equity Prices a Platform or an Add-On

Private equity is a financial buyer. They buy with a fund’s money and debt, operate under a plan, and sell or recapitalize later. They do not have your competitor’s plant. They have a model.

A platform is the first company in a theme, or the company the others will be bolted onto. They underwrite your adjusted EBITDA, the management team that can run it without the founder in every meeting, and a path to grow. The multiple is for the business as it stands, plus what they believe a professional owner can add. They are not paying you for synergies you do not have. If your earnings are real and the team stays, a platform price can match a weak strategic and beat a strategic who was never serious.

An add-on is a purchase by a company they already own. Here the sponsor can behave like a strategic. The portfolio company may have the synergy — a route next to yours, a plant with open capacity, a product that fills a gap. Add-on prices are often lower than platform prices for a company of the same quality, because you are not the bet, you are a piece of someone else’s bet. They rise when you are the missing piece and the platform will pay to keep you out of a competitor’s hands.

In both cases the offer is usually a mix:

• Cash at closing for most of your shares
• A rollover, often a minority stake, so you own a piece of the company beside the fund
• Sometimes a seller note or an earn-out if a customer, a contract, or a year of growth will not clear the lender
• Debt on the company going forward, which is their problem until it affects the value of the shares you kept

The rollover is the sentence under the headline. A “$20 million” PE offer with 20 percent rolled is $16 million of gross proceeds before taxes, debt, and fees, plus a stake you cannot sell on your own timetable. If the next sale happens at a higher value and your shares participate, the stake can be worth more than the cash you left behind. If the next sale disappoints, the debt is paid first, or your class of shares sits behind the fund’s preference, the stake can be worth little. Read the shareholders’ agreement — and how rollover equity and a second bite actually work — before you compare that offer to a strategic’s all-cash number.

What you give up in a PE deal, even when the cash is fair:

• A board. You may keep a seat. You will not be the only vote. Budgets, hiring, add-on acquisitions, and your own compensation go through that board.
• A reporting calendar. Monthly financials, a quality of earnings standard, and a forecast you will be measured against. Owners who have run on a tax return feel this immediately.
• A hold period. Funds often expect to own the company for something like four to seven years. Your rollover is illiquid for that stretch, sometimes longer. You do not pick the day of the second sale.
• A job, if you stay. Many platform deals want the founder for a defined period, then a general manager. “Partnership” in the teaser is an employment agreement, a non-compete, and an equity grant with vesting. Price the job separately from the company.
• The full exit. You wanted out. A rollover means you are still in, with less control than you had on Monday.

When the Lower PE Number Is the Better Net Outcome

Compare offers on the wire and on the life you want after closing, not on the first number in the email.

A strategic headline is worse for you when:

• A large share of it is an earn-out tied to synergies their sales force may never deliver
• Diligence is where they “find” the customer concentration they already knew about, and the premium disappears after you are exclusive
• The cash is real, but the non-compete and the indemnity leave you unable to work and still on the hook for their integration mistakes
• They are a slow committee, and a year of exclusivity costs you the other buyer

A PE number that looks lower on paper can be the better outcome when:

• More of it is cash at closing, and the rollover is a defined percentage of a company you are willing to keep building
• The strategic’s higher number depended on firing a team you will not sell out from under, and the PE firm needs that team
• You want a second sale. A strategic pays you once. A sponsor pays you once now and, if the plan works and your shares are in the money, again later
• The strategic cannot assign your largest contract, and the sponsor is buying the company that already holds it through an equity sale. Structure matters here. See stock versus assets
• Speed and certainty. A sponsor who has done this before, with equity committed and a lender who has read a quality of earnings report, can close. A strategic who “will take it to the board next quarter” can also walk

Run both offers through the same bridge: headline, minus debt-like items, minus the note or earn-out you may never collect, minus taxes your CPA calculates, minus the rollover you cannot spend. What remains is the number to compare. Then ask a second question the spreadsheet will not answer: do you want to be done, or do you want a partner for the next company?

Owners who only wanted to be done should be slow to trade cash for a rollover story. Owners who still like the business, and who trust the team, should be slow to take a strategic premium that ends the company they built.

Who Shows Up in Manufacturing, Specialty Services, and Technology

Bridge Point spends its time with owners in these three lanes. The buyer who “wins” is not the same in each.

Manufacturing

Strategics often pay up when the asset is physical and the fit is obvious: a process you have and they subcontract, a customer qualification that took years, a plant in a region they need, purchasing scale on resin, steel, or components. They will tour the floor and price the equipment and the people who keep it running. Private equity pays for a platform with a general manager already in place, a second shift that is not the founder, and a book of customers that is not one OEM. An add-on sponsored by a fund that already owns a similar plant can look like a strategic and close like one — their synergy is real because the platform company will use your capacity. A fund buying a single plant with no team and no second acquisition in sight should be priced as a financial buyer of a standalone company, not as a synergy story. Concentration with one OEM is where strategics and sponsors diverge: the strategic who is not that OEM may still want the capability; the sponsor will haircut it. See customer concentration.

Specialty services

Testing, inspection, route work, specialty trades, professional field services, and similar companies with a contract or a recurring visit. Private equity has been an active buyer here because the model repeats: buy a platform, add branches, professionalize the back office. They pay for recurring revenue and contracts a manager can keep, and they pay less when the founder is still the estimator and the rainmaker. Strategics — a larger firm in the same service, or a customer bringing the work in house — pay when a license, a geography, or a crew is hard to hire. They may pay more than a sponsor for a single city if it fills their map, and less if they believe they can hire the crew without buying you. If your contracts cannot be assigned, the strategic asset sale gets slower than a sponsor’s equity purchase. That timing belongs in the comparison, not in a footnote.

Technology

Strategics pay for a product, a customer cohort, or a team they cannot hire fast enough. The risk for the seller is an acqui-hire in disguise: the price is for the people, the product is shelved, and an earn-out depends on a roadmap they control. Read retention bonuses and the earn-out as the real price. Private equity and growth investors pay for recurring revenue, net retention, and a team that is broader than the founder. They will not pay a software multiple for a services firm that happens to have a portal. They will pay a services multiple, or they will pass. A strategic in your exact niche can outbid a fund when your product closes a hole in theirs. A fund can outbid a strategic when you still want to build, the revenue renews, and the strategic’s offer is a job for your engineers plus a modest cash number for you.

In all three lanes the process should include both kinds of buyers unless you already know you will not accept one’s terms. A one-buyer conversation is how a strategic convinces you that their number is the market. It is also how a sponsor convinces you that a rollover is standard. Market means more than one offer, built on the same earnings definition.

How to Run the Comparison Before You Grant Exclusivity

Put both buyers on one page before anyone gets a lock-up.

• Same earnings number. If the strategic is using a synergy-adjusted EBITDA and the sponsor is using your standalone EBITDA, you are comparing different companies. Show both, and label them.
• Cash at closing, seller note, earn-out, and rollover, each in dollars.
• What happens to the name, the team, and your role in the first year.
• The non-compete: industry, geography, and years.
• Who must approve, and by what date. A board meeting is a date. “We are socializing it internally” is not.
• The financing. A sponsor with committed equity and a lender is a different certainty than a strategic who will pay cash from a balance sheet — and a strategic’s balance sheet is only certain when the parent has approved the wire.

Then decide what you are selling. If you are selling a finish, weight the strategic who will pay cash and can close, and treat a lower PE bid with a heavy rollover as a job offer plus a minority investment. If you are selling a partnership for the next company, weight the sponsor whose add-on logic is real and whose shareholders’ agreement you can live with, and treat a strategic premium that ends the business as a different life.

If one of those buyers wrote you before you were in a process, answer the unsolicited offer without sending numbers, then put both buyer types on the list. A valuation that states standalone earnings, before anyone’s synergy slide, is the anchor. M&A advisory is the process that keeps both buyers in the conversation until the wire, not the teaser, is comparable.

If you are choosing between a private equity firm and a strategic buyer — or you are getting one call and wondering whether the other exists — Bridge Point can help you frame the number and run a confidential process. Start with a business valuation, M&A advisory, or contact us. Call (352) 515-0226.